HP Inc.
HPQ
$0.00
+15.25%
HP Inc. is a global technology company operating in the Computer Hardware industry, focused on personal computing and printing solutions. As a behemoth in the PC and printing markets, the company is a market leader with a distinct competitive identity built on a broad global customer base, a strong commercial focus, and a completely outsourced manufacturing model. The current investor narrative revolves around its cyclical exposure to the PC market, its ongoing transformation within a mature industry, and its performance amidst a broader AI-led tech rally, as recent news highlights the stock's participation in market highs while underlying concerns about consumer sentiment and inflation persist.…
HPQ
HP Inc.
$0.00
Related headlines
Investment Opinion: Should I buy HPQ Today?
Rating & Thesis: HPQ is rated a Hold. The core thesis is that while the stock appears deeply undervalued and offers a high yield, its structural challenges and bearish analyst sentiment create significant headwinds that likely cap near-term upside, making it suitable only for risk-tolerant, income-oriented value investors. The analyst consensus leans bearish/neutral, reflecting this cautious outlook.
Supporting Evidence: The Hold rating is supported by four key data points. First, valuation is compelling with a forward P/E of 8.48x and a P/S of 0.47x, suggesting limited further multiple compression. Second, the company generates substantial free cash flow ($2.88B TTM) to fund its 4.2% dividend yield. Third, recent quarterly revenue showed positive 6.92% YoY growth. Fourth, the stock's dramatic 23.48% 1-month surge indicates a potential technical bottom, reducing immediate downside risk.
Risks & Conditions: The biggest risks are the leveraged balance sheet (negative D/E), cyclical PC market exposure, and inconsistent earnings. This Hold would upgrade to a Buy if the company demonstrates sustained revenue growth above 5% for two consecutive quarters while maintaining operating margins above 6%, signaling a durable turnaround. It would downgrade to a Sell if the stock breaks below its 52-week low of $17.56 or if quarterly free cash flow turns negative. Relative to its own history and the low-growth hardware sector, the stock is fairly valued to slightly undervalued, but the valuation discount is justified by its risk profile.
Sign up to view all
HPQ 12-Month Price Forecast
The AI assessment is neutral based on conflicting signals: compelling valuation and cash flow versus poor momentum and weak balance sheet health. The high free cash flow yield and dividend provide a floor, but the stock lacks a clear growth catalyst to drive a sustained re-rating. The stance would upgrade to bullish if the company reports two consecutive quarters of revenue acceleration above 5% while improving its current ratio. It would turn bearish if the stock loses its recent momentum and breaks below the $22 support level, signaling the rally was merely a dead-cat bounce.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on HP Inc.'s 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
5 analysts
Implied Upside
—
vs. current price
Analyst Count
5
covering this stock
Price Range
$0 - $0
Analyst target range
Analyst coverage for HPQ is limited, with only 5 analysts providing estimates according to the data. The institutional ratings show a bearish sentiment, with recent actions including multiple 'Underweight' or 'Underperform' ratings from firms like Morgan Stanley, Wells Fargo, Barclays, and B of A Securities, and a 'Sell' from Goldman Sachs. Neutral or 'In Line' ratings from Citigroup, UBS, and Evercore ISI Group round out the coverage, indicating a consensus that leans bearish to neutral. The average target price is not provided in the data, so implied upside cannot be calculated. The target range for estimated EPS is provided, from a low of $3.60 to a high of $3.97, with an average of $3.83. The wide range in revenue estimates, from $55.99 billion to $60.43 billion, signals significant uncertainty among analysts regarding the company's future top-line performance. A high target likely assumes successful execution, margin stability, and perhaps a cyclical upturn in PC demand, while a low target likely factors in competitive pressures, margin compression, and a weaker macroeconomic environment. The pattern of recent analyst actions shows stability in ratings but an overall cautious stance, with no upgrades visible in the provided data. The limited coverage and bearish lean suggest the stock is not a high-conviction idea for most institutional investors, which can contribute to higher volatility.
Bulls vs Bears: HPQ Investment Factors
The investment debate for HPQ centers on a classic value versus value trap dilemma. The bull case is supported by compelling valuation metrics, strong cash flow, and a recent technical breakout, suggesting the market has overcorrected. The bear case highlights severe underperformance, a problematic balance sheet, and a lack of analyst conviction, questioning the sustainability of the rally. Currently, the bearish evidence holds stronger weight due to the stock's persistent long-term downtrend and fundamental weaknesses. The single most important tension is whether the company's robust free cash flow and low valuation can overcome its structural challenges in a mature, cyclical industry and justify a sustained re-rating, or if the recent surge is merely a temporary bounce within a longer-term decline.
Bullish
- Deeply Undervalued on P/E and P/S: HPQ trades at a trailing P/E of 10.35x and a forward P/E of 8.48x, which is near the bottom of its historical range. Its Price-to-Sales ratio of 0.47x is also extremely low, suggesting the market is pricing in significant pessimism, potentially creating a value opportunity if fundamentals stabilize.
- Strong Free Cash Flow Generation: The company generated $2.88 billion in free cash flow over the trailing twelve months, providing significant capital for shareholder returns and operational flexibility. This robust cash generation supports its 4.2% dividend yield and buybacks, offering a tangible return to investors.
- Recent Technical Momentum Reversal: The stock has surged 23.48% over the past month and 35.77% over three months, including a +15.25% single-day jump. This sharp recovery from near its 52-week low suggests a potential oversold bounce and trend reversal, breaking the prior downtrend.
- Positive Revenue Growth and Profitability: Latest quarterly revenue grew 6.92% year-over-year to $14.44 billion, and the company reported net income of $545 million. Despite volatility, HPQ remains consistently profitable, with a gross margin of 19.64% and operating margin of 5.26% in the latest quarter.
Bearish
- Severe Long-Term Underperformance: HPQ has underperformed the S&P 500 by -39.32% over the past year, with a 1-year price change of -11.44% versus SPY's +27.88%. This reflects deep-seated investor skepticism about its growth prospects and cyclical exposure in a mature industry.
- Weak Balance Sheet and Negative Equity: The company's debt-to-equity ratio is a highly negative -31.45, indicating negative shareholder equity and a leveraged capital structure. The current ratio of 0.77 signals potential liquidity constraints in covering short-term obligations.
- Analyst Sentiment is Bearish to Neutral: Recent analyst actions include multiple 'Underweight', 'Underperform', and 'Sell' ratings from major firms like Morgan Stanley and Goldman Sachs. The limited coverage (5 analysts) and cautious consensus suggest low institutional conviction.
- High Volatility and Cyclical Exposure: With a beta of 1.108, HPQ is 11% more volatile than the market, and it has experienced a maximum drawdown of -37.99%. Its fortunes are heavily tied to the cyclical PC market, as evidenced by 71% of revenue coming from the Personal Systems segment.
HPQ Technical Analysis
The stock is in a pronounced downtrend over the past year, evidenced by a 1-year price change of -11.44%, significantly underperforming the SPY's +27.88% gain. As of the latest close at $25.24, the price is trading at approximately 21% of its 52-week range ($17.56 to $29.55), positioning it much closer to its 52-week low, which suggests a potential value opportunity but also reflects significant fundamental and technical weakness. The stock has experienced a maximum drawdown of -37.99% over the observed period, indicating severe volatility and investor pessimism. Recent momentum shows a sharp but volatile recovery, with a 1-month price surge of +23.48% and a 3-month gain of +35.77%, dramatically diverging from the negative longer-term trend. This short-term acceleration, highlighted by a +15.25% single-day jump on May 22nd, suggests a potential trend reversal or a significant oversold bounce, though it conflicts with the stock's relative strength versus the market, which remains deeply negative at -39.32% over one year. The beta of 1.108 indicates the stock is roughly 11% more volatile than the broader market, which is relevant for risk assessment. Key technical levels are clearly defined, with immediate support at the 52-week low of $17.56 and major resistance at the 52-week high of $29.55. A sustained breakout above the recent high of $25.90 (from early December 2025) would be the first step toward challenging the 52-week high, signaling a potential end to the downtrend. Conversely, a breakdown below the $17.56 support would signal a new leg down and likely trigger further selling. The stock's volatility, as shown by the beta and the dramatic 1-month move, necessitates careful position sizing for risk management.
Beta
1.11
1.11x market volatility
Max Drawdown
-38.0%
Largest decline past year
52-Week Range
$18-$30
Price range past year
Annual Return
-11.4%
Cumulative gain past year
| Period | HPQ Return | S&P 500 |
|---|---|---|
| 1m | +23.5% | +4.4% |
| 3m | +35.8% | +8.5% |
| 6m | +5.3% | +9.7% |
| 1y | -11.4% | +28.8% |
| ytd | +14.1% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HPQ Fundamental Analysis
Revenue growth is modest but positive, with the most recent quarterly revenue of $14.44 billion representing a year-over-year growth of 6.92%. However, examining the multi-quarter trend reveals inconsistency; revenue declined sequentially from $14.64 billion in Q4 2025 and has fluctuated between $13.20 billion and $14.64 billion over the last five quarters. Segment data shows the Personal Systems Group ($10.25B) is the primary growth driver over Printing ($4.19B), indicating the company's fortunes remain heavily tied to the cyclical PC market. The company is profitable, reporting net income of $545 million for the latest quarter. Gross margin for the quarter was 19.64%, which is consistent with the trailing gross margin of 19.98% from the key metrics. Operating margin was 5.26% for the quarter, aligning with the valuation data's operating margin of 6.55%. Profitability has been volatile quarter-to-quarter, with net income ranging from $406 million to $906 million over the past two years, reflecting the impact of input costs and demand cycles on this low-margin hardware business. Balance sheet health shows mixed signals. The company generated substantial free cash flow over the trailing twelve months ($2.88 billion) and had an operating cash flow of $383 million in the latest quarter. However, the current ratio of 0.77 indicates potential liquidity constraints in covering short-term obligations. The debt-to-equity ratio is a highly negative -31.45, which is an accounting anomaly typically resulting from negative shareholder equity, signaling a leveraged capital structure that warrants deeper investigation. Return on Equity is also deeply negative at -7.31%, while Return on Assets is a modest but positive 5.62%.
Quarterly Revenue
$14.4B
2026-01
Revenue YoY Growth
+0.06%
YoY Comparison
Gross Margin
+0.19%
Latest Quarter
Free Cash Flow
$2.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HPQ Overvalued?
Given a positive Net Income of $545 million in the latest quarter, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 10.35x, while the forward PE is lower at 8.48x. This gap suggests the market anticipates earnings growth, with forward estimates implying an earnings per share of approximately $2.98 based on the current price, a significant increase from the trailing twelve-month EPS of $0.097. Peer comparison is challenging due to missing industry average data in the provided valuation set. However, the stock's trailing PE of 10.35x and Price-to-Sales ratio of 0.47x appear low on an absolute basis, potentially indicating a discount relative to the broader technology sector, though this discount may be justified by the company's mature, low-growth profile and thin margins compared to high-growth tech peers. Historical context shows the current trailing PE of 10.35x is below the stock's own historical range observed in the data, which has seen PE ratios fluctuate from as low as 2.84x to over 15x in recent years. The current PS ratio of 0.47x is also near the bottom of its historical band, which has ranged above 2.0x. Trading near the bottom of its own historical valuation ranges suggests the market is pricing in pessimistic expectations, potentially offering a value opportunity if the company's fundamentals stabilize or improve.
PE
10.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -3383x~15x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: HPQ faces significant financial risks stemming from its capital structure. The negative debt-to-equity ratio of -31.45 and negative Return on Equity (-7.31%) indicate a leveraged balance sheet with negative shareholder equity, a red flag that warrants deeper due diligence. Profitability is volatile, with quarterly net income swinging by over $500 million year-over-year, exposing investors to earnings uncertainty. While free cash flow is strong at $2.88 billion TTM, the low current ratio of 0.77 suggests potential strain in meeting short-term liabilities, which could pressure operations during a downturn.
Market & Competitive Risks: The stock trades at a deep discount (P/E of 10.35x, P/S of 0.47x) which, while appearing cheap, may reflect a justified 'value trap' status due to its mature, low-growth profile in the competitive PC and printing hardware markets. Its beta of 1.108 indicates it is more volatile than the market, and recent news highlights its participation in an AI-led tech rally masks underlying consumer sentiment weakness and inflation fears that could limit PC refresh cycles. The company is highly exposed to macroeconomic sensitivity, with only one-third of sales from the US, making it vulnerable to global demand shifts and potential tariff threats.
Worst-Case Scenario: The most damaging scenario involves a severe cyclical downturn in the PC market coinciding with margin compression from input cost inflation, triggering a double miss on revenue and earnings. This could lead analysts to cut EPS estimates towards the low end of the range ($3.60), and the stock could re-test its 52-week low of $17.56 as investor patience evaporates. Given the stock's history of a -37.99% max drawdown, a realistic downside from the current price of $25.24 could be approximately -30%, falling to the $17.56 support level. This would be exacerbated by a potential dividend cut if cash flow weakens, removing a key support for the stock.
FAQ
The key risks are, in order of severity: 1) Financial Risk: A highly leveraged balance sheet with negative shareholder equity (Debt/Equity: -31.45) and a weak current ratio (0.77). 2) Cyclical/Market Risk: Heavy exposure to the volatile PC market, which drives 71% of revenue, making earnings highly sensitive to economic cycles. 3) Competitive Risk: Operating in low-margin, mature hardware segments with intense competition, limiting pricing power. 4) Sentiment Risk: Persistent bearish analyst coverage and a history of severe underperformance (-11.44% 1-year return) which can limit buying interest and increase volatility.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $24 and $27, as it meets modest growth expectations and its valuation remains depressed. The Bull Case (25% probability) targets $29.55 to $32, driven by a strong PC cycle and earnings beats. The Bear Case (15% probability) warns of a drop to $17.56-$21 if demand weakens and margins compress. The most likely outcome is the base case, where HPQ's high cash flow and dividend provide support, but structural challenges prevent a major re-rating. The average analyst EPS forecast for the forward year is $3.83.
HPQ appears statistically undervalued on an absolute basis. It trades at a trailing P/E of 10.35x, a forward P/E of 8.48x, and a Price-to-Sales ratio of 0.47x, all near the bottom of its historical range. This suggests the market is paying a deep discount, likely pricing in pessimistic expectations for growth and margin stability. However, this discount may be justified (a 'value trap') given the company's mature markets and financial leverage. The valuation implies the market expects minimal growth and carries significant risk, which is why the stock is cheap.
HPQ is a speculative buy only for specific investor profiles. For income-focused value investors willing to tolerate high volatility and cyclical risk, the 4.2% dividend yield and low forward P/E of 8.48x may be attractive. However, given its -39% underperformance versus the market over the past year, negative shareholder equity, and bearish analyst sentiment, it is not a high-conviction growth investment. It could be a good buy for those betting on a mean reversion in valuation, but they must be prepared for further downside, potentially to the $17.56 support level.
HPQ is more suitable for a long-term investment horizon of 3+ years, not short-term trading. As a value and income stock, its thesis relies on the eventual realization of its cash flow generation and a potential cyclical recovery, which takes time. Its high beta of 1.108 and history of a -37.99% drawdown make it too volatile for short-term positions. The 4.2% dividend yield also favors a buy-and-hold approach to collect income while waiting for valuation improvement. A minimum holding period of 18-24 months is suggested to ride out potential industry cycles and assess turnaround progress.
